Acer Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Acer Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2022.
  • Acer Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$1.85M, a 898% decline year-over-year.
  • Acer Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$21.1M, a 943% decline year-over-year.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$1.62M, a 383% decline from 2021.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $574K.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2020 was -$82.6K, a 117% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.62M -$2.2M -383% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $574K +$657K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$82.6K -$562K -117% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $479K +$46.4K +10.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $433K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.